VOLITIONRX LTD
{{company.company_channel.channel_name}}
Media Room
{{company.company_name_local}}
{{company.company_channel.channel_name}}
Company Profile
Media Room
VolitionRx to Present at Two Conferences in November 2015-11-12 20:00
VolitionRx Announces Third Quarter 2015 Financial Results and Business Update 2015-11-04 19:30
VolitionRx Schedules Third Quarter 2015 Earnings Conference Call and Business Update for Wednesday, November 4, 2015 at 8:30am ET 2015-10-30 19:00
VolitionRx Announces Publication of Results from Pancreatic Cancer Study with Lund University in Clinical Epigenetics 2015-10-12 19:00
VolitionRx Announces First CE Mark for NuQ(R) Blood Assay for Detection of Colorectal Cancer 2015-09-22 19:00
VolitionRx Granted Its First U.S. Patent 2015-09-10 19:00
VolitionRx Demonstrates NuQ(R) Blood Test Detects 81% of Colorectal Cancers and 67% of High Risk Adenomas in Large Double Blinded Clinical Trial 2015-09-09 20:00
VolitionRx to Present at Rodman & Renshaw 17th Annual Global Investment Conference in New York and CNAPS IX Conference in Berlin on September 9 and 11, 2015 2015-09-02 20:00
VolitionRx to Attend 10th Annual Wells Fargo Healthcare Conference on September 9-10, 2015 2015-09-01 20:00
VolitionRx Announces Appointment of David Kratochvil as Chief Financial Officer 2015-08-17 20:00
VolitionRx Announces Second Quarter 2015 Financial Results and Business Update 2015-08-11 18:30
VolitionRx Schedules Second Quarter 2015 Earnings Conference Call and Business Update for Tuesday, August 11, 2015 at 8:30am ET 2015-08-05 20:00
VolitionRx to Present at Wedbush PacGrow Healthcare Conference 2015-08-03 20:00
VolitionRx Engages Specialty Clinical Research Organization to Support Initial Entry of its NuQ(R) Colorectal Cancer Tests via U.S. CLIA Labs 2015-07-27 20:00
VolitionRx CSO Dr. Jake Micallef to Present Scientific Webinar 2015-07-08 20:00
VolitionRx Expands Scientific Advisory Board 2015-07-06 20:18
VolitionRx Partners with Two Market Access Consulting Agencies to Support Market Access of NuQ(R) Colorectal Cancer Tests in Europe 2015-06-23 20:00
VolitionRx CEO Cameron Reynolds to Present Informational Webinar 2015-05-18 20:00
VolitionRx Announces First Quarter 2015 Financial Results and Business Update 2015-05-12 19:50
VolitionRx Accelerates Clinical Trial with University Hospital Bonn, Germany Evaluating NuQ(R) Assays in Most Prevalent Cancers 2015-05-08 20:00
1 7 8 9 10 11